Kinderhook Industries acquires Enhabit Home Health & Hospice

Kinderhook Industries, a private equity firm with a focus on middle-market investments, has agreed to acquire Enhabit, Inc., a prominent provider of home health and hospice services. The transaction values Enhabit at approximately $1.1 billion. This purchase is structured as an all-cash deal, in which Enhabit shareholders will receive $13.80 per share. This figure represents a premium of 24.4% over Enhabit's closing stock price prior to the deal’s announcement. The offer also marks a 33.8% premium over the 60-day volume-weighted average share price leading up to the announcement on February 20, 2026.

Once the transaction is finalized, Enhabit will be delisted from the New York Stock Exchange and transition to a private company. While the company will operate under the same branding, this shift away from the scrutiny of public markets may allow greater flexibility in long-term strategic planning and allocation. The acquisition has received unanimous approval from Enhabit's Board of Directors, and stockholders are expected to approve the deal, alongside the necessary regulatory clearances, in the second quarter of 2026.

The strategic rationale from Enhabit’s perspective is underscored by the belief that going private will maximize value for shareholders while also advancing its operational mission. Jeffrey W. Bolton, Chairman of Enhabit, stated that the board conducted a thorough evaluation of the company’s status and opportunities, asserting that Kinderhook’s acquisition is in the best interest of the stakeholders involved. Barb Jacobsmeyer, Enhabit’s CEO, emphasized the potential benefits of this new ownership structure, highlighting Kinderhook’s additional resources as key to bolstering clinical excellence and innovation efforts free from public market constraints.

Kinderhook, known for a 20-year track record of collaborating with industry-leading firms, considers this acquisition an opportunity to support Enhabit’s established patient-centric approach and market leadership in home-based care. Chris Michalik, a Managing Director at Kinderhook, remarked that their growth-oriented strategy is designed to help companies concentrate on core operations and quality improvement. Matt Bubis, also of Kinderhook, lauded Enhabit’s strong leadership and care teams, suggesting the firm plans to eliminate operational barriers and foster the company’s existing foundation.

Looking forward, the acquisition's completion is contingent upon obtaining the necessary shareholder approvals and regulatory clearances. Kinderhook has secured committed financing, ensuring the transaction's path to closure. The focus will remain on navigating any regulatory hurdles and concluding the transaction by the expected date in the second quarter of 2026, setting the stage for Enhabit's next chapter as a private enterprise.